PeptidePedia The community reference

Contributions of ReportReaderRilla

User contributions·33 logged edits·page 1 of 1

Contributions by ReportReaderRilla, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 2,422 edits includes activity predating the current log.

  1. 23:33, 10 May 2026 (diff | hist) WuXi TIDES 13,269 ±0 split section
  2. 16:50, 22 Mar 2026 (diff | hist) Shanghai Wibson Biotechnology 11,996 ±0 add citation
  3. 17:17, 16 Mar 2026 (diff | hist) Zhuhai Kerui Biotechnology 12,118 ±0 clarify whether figure is gross or net mass
  4. 05:25, 13 Mar 2026 (diff | hist) Guangzhou JEEP Biotechnology 12,891 ±0 add DOI
  5. 12:05, 2 Mar 2026 (diff | hist) Shanghai Sigma-Audley New Material Technology 12,666 ±0 remove weasel wording
  6. 03:52, 15 Feb 2026 (diff | hist) Cold chain 27,220 ±0 rm unsourced claim per PP:V
  7. 23:43, 1 Feb 2026 (diff | hist) ChinaPeptides 12,304 ±0 m rm maintenance tag, addressed
  8. 14:59, 23 Jan 2026 (diff | hist) Xi'an Mokemei Biotechnology 12,289 ±0 fix significant figures — source gives fewer
  9. 12:27, 28 Dec 2025 (diff | hist) Zhuhai Kerui Biotechnology 10,212 +226 m add PMID
  10. 21:44, 13 Dec 2025 (diff | hist) Zhuhai Kerui Biotechnology 9,986 ±0 add PMID
  11. 05:00, 12 Dec 2025 (diff | hist) Qingdao Sigma Chemical 12,284 ±0 consistent en dashes in ranges
  12. 16:09, 12 Nov 2025 (diff | hist) Guangzhou JEEP Biotechnology 12,705 ±0 ce, tighten prose
  13. 07:01, 28 Sep 2025 (diff | hist) Zhuhai Kerui Biotechnology 7,471 ±0 fix arithmetic in worked example
  14. 14:09, 27 Jul 2025 (diff | hist) Chinese Peptide Company 11,690 ±0 m expand §External links
  15. 08:57, 23 Jul 2025 (diff | hist) Qingdao Saber Technology Pharmaceutical 4,746 +641 fix unit
  16. 08:56, 4 Jul 2025 (diff | hist) Shanghai ERP Biotechnology 1,723 ±0 fix hyphenation per PP:MOS
  17. 07:21, 9 Jun 2025 (diff | hist) ChinaPeptides 8,278 ±0 consistent en dashes in ranges
  18. 04:55, 1 May 2025 (diff | hist) Hubei Jianxiang Bioscience 2,765 ±0 cite the trial publication rather than the press release
  19. 17:59, 10 Apr 2025 (diff | hist) Hubei Jianxiang Bioscience 2,167 +450 correct percentage: source reports placebo-adjusted
  20. 23:47, 15 Mar 2025 (diff | hist) GL Biochem (Shanghai) 11,663 +1,593 consistent en dashes in ranges
  21. 08:04, 12 Mar 2025 (diff | hist) WuXi TIDES 8,673 ±0 m add DOI
  22. 15:43, 14 Feb 2025 (diff | hist) Tianjin Finder Chemical 5,843 ±0 restructure
  23. 05:29, 9 Jan 2025 (diff | hist) Qingdao Sigma Chemical 6,212 +288 add PMID
  24. 21:10, 26 Dec 2024 (diff | hist) Glucose-dependent insulinotropic polypeptide 5,605 ±0 m lead should summarise the body, not add to it
  25. 00:30, 25 Dec 2024 (diff | hist) Sangon Biotech 2,448 +283 convert list to prose
  26. 04:42, 15 Nov 2024 (diff | hist) Tianjin Finder Chemical 2,727 +747 m move unsourced paragraph to talk
  27. 16:24, 10 Nov 2024 (diff | hist) Bachem Holding (Suzhou) 3,329 ±0 add citation for the incidence figure
  28. 21:09, 28 Sep 2024 (diff | hist) WuXi TIDES 4,373 ±0 add see also
  29. 17:30, 13 Sep 2024 (diff | hist) Nantong Guangyuan Chemical 3,483 +696 cite the trial publication rather than the press release
  30. 19:21, 12 Sep 2024 (diff | hist) Wuhan Wansheng Biotechnology 4,943 +33 m add PMID
  31. 23:31, 3 Aug 2024 (diff | hist) Chinese Peptide Company 1,740 ±0 m add citation for the incidence figure
  32. 11:19, 17 Jul 2024 (diff | hist) GL Biochem (Shanghai) 2,831 ±0 m correct transposed digits
  33. 05:32, 4 Jul 2024 (diff | hist) Glucose-dependent insulinotropic polypeptide 1,758 ±0 m replace primary source with the review